Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
04/15/2008 | CA2328920C Novel derivatives of 3,3-diphenylpropylamines |
04/15/2008 | CA2171614C Pharmaceutical composition containing sialic acid derivatives |
04/10/2008 | WO2008041843A1 Inhibition of cholera toxins by galatooligosaccharides (gos) |
04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
04/10/2008 | WO2008040756A1 Anandamide |
04/10/2008 | WO2008040548A2 Treatment for non-alcoholic-steatohepatitis |
04/10/2008 | WO2008040155A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
04/10/2008 | WO2008017752A3 Eucalyptus extract, method of preparation and therapeutic uses thereof |
04/10/2008 | US20080086000 Prostaglandin reductase |
04/10/2008 | US20080085938 Arylamino-Arylpropanolamine Derivatives and Methods of Their Use |
04/10/2008 | US20080085921 Emesis, dyspepsia, gastroparesis, constipation, gastroesophageal reflux, or post-operative ileus; cisapride analogs; side effect reduction of adverse events; (R)-quinuclidin-3-yl 6-((3S,4R)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate or salts |
04/10/2008 | US20080085915 Emesis, dyspepsia, gastroparesis, constipation, gastroesophageal reflux, or post-operative ileus; stereoisomeric esterified cisapride analogs; side effect reduction of adverse events by avoiding the cytochrome P450 drug detoxification system |
04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
04/10/2008 | US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example |
04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
04/10/2008 | US20080085321 Administering fermented milk/cheese whey as active component; necrosis |
04/10/2008 | US20080085296 Methods for reduction of post operative ileus. |
04/10/2008 | US20080085280 Using monoclonal antibody specific to bacterial ectodomain as tool in prevention and treatment of pancreatic, kidney and inflammatory disorders |
04/10/2008 | US20080085268 Using probiotic microorganisms in the treatment and prevention of gastrointestinal inflammation |
04/10/2008 | CA2664413A1 Treatment for non-alcoholic-steatohepatitis |
04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
04/09/2008 | EP1908772A2 Porphorymonas gingivalis polypeptides and polynucleotides |
04/09/2008 | EP1908753A1 Novel heterocyclidene acetamide derivative |
04/09/2008 | EP1908492A1 Metabotropic glutamate receptor activator |
04/09/2008 | EP1908480A1 Interferon- alpha regulator |
04/09/2008 | EP1908449A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
04/09/2008 | EP1907376A2 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
04/09/2008 | EP1906983A2 Cynara scolymus extracts, the use thereof ans formulations containing them |
04/09/2008 | EP1906951A2 Compositions and methods for treating gastrointestinal hypomotility and associated disorders |
04/09/2008 | EP1906944A1 Schisandrin b preparation |
04/09/2008 | EP1906917A2 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
04/09/2008 | EP1345613B1 Probiotic compounds derived from lactobacillus casei strain ke01 |
04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
04/09/2008 | EP1124551B1 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
04/09/2008 | CN101160307A Benzoxazole carboxamides for treating cinv and ibs-d |
04/09/2008 | CN101160306A 苯并咪唑化合物 Benzimidazole compounds |
04/09/2008 | CN101160134A Selection and use of lactic acid bacteria for reducing inflammation in mammals |
04/09/2008 | CN101157717A Preparation method of Ardisia mamillata B and uses thereof |
04/09/2008 | CN101157696A Mulberry roots phenol A compound, preparation method and application thereof |
04/09/2008 | CN101157689A Complex salt of Silybin and oxymatrine or matrine and uses thereof |
04/09/2008 | CN101156942A Medicine combination for treating relapse stomatocace and chronic pharyngitis |
04/09/2008 | CN101156938A A formulation for treating appendicitis |
04/09/2008 | CN101156936A An administer orally mixed nucleus glycosides as well as its preparing technics |
04/09/2008 | CN101156928A A Subhealth treating Chinese medicine composition and method of making the same |
04/09/2008 | CN101156926A A traditional Chinese medicine preparation for removing food retention and promoting digestion of animals use as well as its preparing method and quality control method |
04/09/2008 | CN101156910A A dysentery stopping traditional Chinese medicine preparation for animals and method for making same as well as quality control method |
04/09/2008 | CN101156907A A pueraria root scutellaria and coptis extract |
04/09/2008 | CN101156906A A pueraria root scutellaria and coptis medicinal composition |
04/09/2008 | CN101156886A A composition for regulating intestinal canal flora and improving hypoxiatolerance force as well as its preparation method |
04/09/2008 | CN101156877A A sobering-up agent |
04/09/2008 | CN101156857A A composite vitamine and its preparation method as well as application |
04/09/2008 | CN101156856A Falacyclovir dispersion piece and its preparation method |
04/09/2008 | CN101156852A Lansoprazole intestine solution capsule and its preparation method |
04/09/2008 | CN101156849A An alepsin slow-releasing gel for promoting paradontal part reborn as well as preparation method and application |
04/09/2008 | CN101156846A A buccal pellicle for treating gingivitis and oral mucosa canker as well as its preparation method |
04/09/2008 | CN101156842A Pharmaceutical preparation containing arginine glutamic acid |
04/09/2008 | CN101156839A White hellebore alcohol and red phenolic acid B compound recipe preparation and its application |
04/09/2008 | CN101156836A A method for forming dextran 40/ polypeptide freeze dried powder injection solution |
04/09/2008 | CN101156834A Ammonia temperature responsive form gel and its preparation method |
04/09/2008 | CN101156685A Health-care nutritive mush |
04/09/2008 | CN100379762C Interfusion protein between human serum albumin and interleukin, and encoding genes |
04/09/2008 | CN100379744C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
04/09/2008 | CN100379737C Thioxanthine derivatives as myeloperoxidase inhibitors |
04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
04/09/2008 | CN100379734C Azaindoles |
04/09/2008 | CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives |
04/09/2008 | CN100379451C 疫苗 Vaccine |
04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
04/09/2008 | CN100379446C Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
04/09/2008 | CN100379435C Bone-strengthening kidney-supplementing pill |
04/09/2008 | CN100379430C Sturgeon chondroition capsule and instant granula preparation method therefor |
04/09/2008 | CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser |
04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
04/09/2008 | CN100379349C Method for preparing immune milk anti-pathogenic microoganism in digestive tract |
04/08/2008 | US7355015 Matriptase, a serine protease and its applications |
04/08/2008 | US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
04/08/2008 | US7354910 Agent for treating inflammatory bowel diseases |
04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
04/08/2008 | US7354570 Extract of Sanguis Draxonis, Radix Paeoniae Rubra, Indigo Naturalis, 1-Halloysitum Rubrum, Catechu, Calcined Alumen, Rhizoma Bletillae and Calamina; enema |
04/08/2008 | CA2337886C Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
04/08/2008 | CA2260315C 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
04/03/2008 | WO2008038841A1 Thiadiazolone derivative and use thereof |
04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
04/03/2008 | WO2007146983A3 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury |
04/03/2008 | WO2007131070A3 Compositions, dosage forms and methods of treating emesis |
04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
04/03/2008 | US20080081796 Treatment of mucositis |
04/03/2008 | US20080081073 Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease |